Vertex Pharmaceuticals
VRTX
VRTX
516 hedge funds and large institutions have $29.5B invested in Vertex Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 192 increasing their positions, 181 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less call options, than puts
Call options by funds: $88.4M | Put options by funds: $117M
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
516
Holding in Top 10
5
Calls
$88.4M
Puts
$117M
Top Buyers
| 1 | +$482M | |
| 2 | +$181M | |
| 3 | +$177M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$143M |
| 5 |
AIM
abrdn Investment Management
Edinburgh,
United Kingdom
|
+$98.5M |
Top Sellers
| 1 | -$337M | |
| 2 | -$246M | |
| 3 | -$206M | |
| 4 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$195M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$71.9M |